Detailed testing to better describe postural orthostatic tachycardia syndrome
Studies people with postural orthostatic tachycardia syndrome using several kinds of tests.
Key facts
- Who runs it
- University of Texas Southwestern Medical Center
- Where
- Dallas, United StatesSee the site
- Trial code
- Registry title
- Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)
- Status
- Recruiting
- People taking part
- 350 people, planned
- Started
- 5 Mar 2024
- Expected to end
- Jan 2029
- Type of study
- Observational, 2 groups
- Treatments tested
- multimodal diagnostic testing
- Record updated
- 17 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with POTS, a condition where the heart beats much faster on standing. It also takes healthy young women as a comparison group.
- Age
- POTS patients: 14 years and older (under 18 with parental consent). Healthy controls: women aged 18 - 30 years.
- Sex
- POTS patients: all sexes. Healthy controls: women only.
- Disease stage
- POTS patients: heart rate rises by ≥ 30 bpm within 10 min of standing or tilt (≥ 40 bpm at ages 12 to 19), or standing heart rate >120 bpm. No drop in blood pressure on standing. Symptoms on standing improve when sitting or lying. Resting heart rate lying down < 100 bpm. Symptoms for at least 6 months. Healthy controls: no POTS, no symptoms on standing, no other major illness.
- Earlier treatment
- POTS patients must be on the same oral medicines for at least 14 days.
Main reasons for not taking part
- Use of stimulants like amphetamines, diuretics, anticholinergic drugs, tricyclic antidepressants, fludrocortisone or desmopressin in the past 14 days.
- Use of other drugs acting on the nervous system (such as pyridostigmine, droxidopa, triptans, ivabradine) in the past 48 hours.
- Currently getting IVIG or subcutaneous IgG, or any study medicine in the past year.
- Fluids given through a vein in the past 7 days.
- Another condition that explains the symptoms, such as structural heart disease, low spinal fluid or severe brain injury.
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- POTS Patients
- Age ≥ 14 years, able to provide informed consent (assent with parental consent for age < 18) and comply with procedures
- Meets consensus criteria for POTS: (1) sustained increase in heart rate ≥ 30 bpm above supine baseline within 10 min of quiet standing or upright tilt (≥ 40 bpm in individuals 12 to 19 years of age) OR sustained upright HR (heart rate) >120 bpm, (2) absence of orthostatic hypotension, (3) symptoms with standing that improve with sitting or lying down, (4) resting supine heart rate < 100 bpm, (5) orthostatic symptoms present for at least 6 months
- Stable oral medication regimen for at least 14 days; Non-POTS Control Patients
- Healthy women, age 18 - 30 years, able to provide informed consent and comply with study procedures
- Does NOT meet consensus criteria for postural tachycardia syndrome
- No symptoms of orthostatic intolerance or dysautonomia. No history of other major medical disorder
- Resting supine heart rate < 100 bpm
Who cannot take part
- Use of amphetamine-type stimulants, diuretics, selective norepinephrine reuptake inhibitor, anticholinergic medications (including tricyclic antidepressant medications), fludrocortisone, desmopressin in past 14 days
- Use of other autonomic drugs (adrenergic agents, pyridostigmine, droxidopa, triptans, ivabradine) in past 48 hours
- Currently receiving IVIG (Intravenous immunoglobulin), subcutaneous IgG (Immunoglobulin G), or any investigational medication (in past year)
- History or evidence of another condition explaining symptoms or orthostatic tachycardia (e.g. structural heart disease, CSF (Cerebrospinal fluid) hypovolemia, or severe traumatic brain injury)
- None of the following exclusion criteria:
- Infusion of iv fluids in past 7 days
Where in United States
- UT Southwestern Medical CenterDallas, United StatesContact: Steven HopkinsTaking people
About the trial
What the trial wants to find out
This is an observational study to deeply phenotype the disorder of POTS using multiple testing modalities.
The 2 groups in the trial
- POTS (Postural Orthostatic Tachycardia Syndrome)
Patients meeting clinical criteria for postural orthostatic tachycardia syndrome who meet other criteria for inclusion.
Treatment: multimodal diagnostic testing
- Healthy matched controls
Age and sex matched controls
Treatment: multimodal diagnostic testing
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multimodality Deep Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS), Aim 1
- Plain-language title
- Detailed testing to better describe postural orthostatic tachycardia syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 17 July 2026